| 83 | 0 | 78 |
| 下载次数 | 被引频次 | 阅读次数 |
目的 探索自制抗双链DNA抗体(dsDNA)室内质控品研制方法,并完成性能验证,为临床实验室dsDNA检验质量保证提供解决方案。方法 收集高滴度(1∶100~1∶320)dsDNA单一荧光核型的临床血清样本,将其与血清样本稀释媒介PBST(含1%吐温的PBS)按不同比例倍比稀释制备成1∶10荧光滴度的弱阳性室内质控品,收集阴性血清制备阴性质控品。将自制弱阳性质控品灭活后采用间接免疫荧光法检测,双人同时进行荧光强度判读,并对自制质控品均一性和稳定性进行验证。结果 自制弱阳性和阴性dsDNA室内质控品均有良好的均一性和稳定性,以自制室内质控品验证仪器也具有良好的重复性和一致性。结论 本室自制的dsDNA室内质控品具有良好的均一性及稳定性,可满足临床检验需求并为其他实验室自制质控品提供理论参考依据。
Abstract:Objective To make the in-house quality control of anti-dsDNA antibody(dsDNA) and complete the performance verification are the prerequisites to ensure the quality of the test. Methods The serum samples of high titer(1∶100-1∶320) dsDNA with a single fluorescent karyotype were collected, and the dilution medium PBST(PBS containing 1% Tween) was prepared into a weakly positive indoor control with a 1∶10 fluorescent titer in different proportions, and also the negative serum was collected to prepare a negative control. The self-made weak positive control was inactivated and detected by indirect immunofluorescence, the fluorescence intensity was interpreted by two people at the same time, and the uniformity and stability of the self-made quality control were verified. Results The in-house controls for self-made weak positive and negative dsDNA had good uniformity and stability, meanwhile the instruments validated with self-made in-house controls are also with good reproducibility and consistency. Conclusion The self-made dsDNA in-house quality control has good uniformity and stability, which can meet the needs of clinical testing and provide a theoretical reference for other laboratory self-made quality controls.
[1] 苏向珠,梅丽春,翟建昭,等.抗dsDNA抗体和抗Sm抗体阳性SLE患者临床及实验室特点研究[J].国际检验医学杂志,2020,41(23):2862-2866.
[2] 王琳,宋红梅.《中国儿童系统性红斑狼疮诊断与治疗指南》解读[J].协和医学杂志,2022,13(3):412-420.
[3] 欧阳芬,张乔轩,李妙言,等.高亲合力抗双链DNA抗体对系统性红斑狼疮的诊断价值[J].蚌埠医学院学报,2021,46(6):803-806.
[4] 李志艳,李丽娟,韩瑞林,等.不同方法检测抗双链DNA抗体在系统性红斑狼疮诊断中的价值评估[J].标记免疫分析与临床,2022,29(7):1179-1183.
[5] Cockx M,Van Hoovels L,De Langhe E,et al.Laboratory evaluation of anti-dsDNA antibodies[J].Clin Chim Acta,2022,528:34-43.
[6] 雪丹,苏真珍,黄卓春,等.间接免疫荧光法检测抗核抗体室内质控品制备和性能验证[J].中华临床免疫和变态反应杂志,2021,15(4):364-369.
[7] 徐超成,罗俭权,陶珊花.抗双链DNA抗体测定阳性在自身免疫性疾病患者中的免疫学特征分析[J].中国实用医药,2022,17(26):96-99.
[8] Aringer M,Costenbader K,Daikh D,et al.2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus[J].Ann Rheum Dis,2019,78(9):1151-1159.
[9] 自身抗体检测在自身免疫性疾病中的临床应用专家建议[C].2019年贵州省中医、中西医结合风湿病学术会议论文集,2019:212-223.
[10] Bauer CJ,Karakostas P,Weber N,et al.Comparative analysis of contemporary anti-double stranded DNA antibody assays for systemic lupus erythematosus[J].Front Immunol,2023,14:1305865.
[11] Kadkhoda K,Schroeder G,Boyert N,et al.Double-stranded DNA antibody test using BioPlex220 system:unacceptable option for SLE diagnosis and follow-up[J].Lab Med,2025,56(2):113-114.
[12] 朱晓雨.ANA、抗ENA抗体联合抗ds-DNA抗体对自身免疫性疾病的诊断价值[J].中国实用医药,2023,18(13):80-82.
[13] Cockx M,Van Hoovels L,De Langhe E,et al.Laboratory evaluation of anti-dsDNA antibodies[J].Clin Chim Acta,2022,528:34-43.
[14] 王丽娟,路颖,韩燕聪,等.化学发光法定量检测抗双链DNA IgG抗体的方法学性能验证[J].海军医学杂志,2023,44 (11):1199-1202.
基本信息:
中图分类号:R446.6
引用信息:
[1]龙明望,付雪,李红梅,等.间接免疫荧光法检测抗双链DNA抗体室内质控品研制及性能验证[J].贵州医药,2025,49(12):1866-1870.
基金信息:
国家自然科学基金地区基金(82360531); 贵州省科技厅-黔科合基础(ZK[2023]一般209); 贵州省卫健委(gzwkj2024-170); 贵州省人民医院青年基金(GZSYQN202218)